TY  -  
T1  - Prognostic importance of the tumour microenvironment in follicular lymphoma patients treated with immunochemotherapy 
SN  -  /  
UR  - URN:ISBN:978-952-10-6785-3; http://hdl.handle.net/10138/24588 
T3  -  
A1  - Taskinen, Minna 
A2  -  
PB  - Helsingin yliopisto 
Y1  - 2011 
LA  - eng 
AB  - Follicular lymphoma (FL) is the second most common non-Hodgkin lymphoma. It is an indolent and clinically heterogeneous disease, which is generally considered incurable. Currently, immunochemotherapy has significantly improved the outcome of FL patients. This is based on the combination of rituximab, a monoclonal anti-CD20 antibody, with chemotherapy, and is used at present as a standard first-line therapy in FL. Thus far, however, patients have been selected for treatment based on clinical risk... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - lääketiede 
N1  -   
PP  -  
ER  -